Business

TCR Director Casey Prince to join Downtown District

File photo: Director Casey Prince critiques the All-American City dress rehearsal at the Cedar Rapids Public Library Tuesday evening, June 10, 2014. (Bill Adams/Freelance)
File photo: Director Casey Prince critiques the All-American City dress rehearsal at the Cedar Rapids Public Library Tuesday evening, June 10, 2014. (Bill Adams/Freelance)

Casey Prince, Executive Director of Theatre Cedar Rapids for the past 10 years, announced his resignation in order to accept the position of Downtown District Executive Director, according to a TCR media release.

The position works with the Cedar Rapids Metro Economic Alliance and the Downtown Self-Supporting Municipal Improvement District (Downtown SSMID), which represents commercial property owners in a 55-block area.

The responsibilities were previously handled by Doug Neumann, who is now serving as interim president and CEO of the Economic Alliance.

Prince has already worked with the Economic Alliance as a member of its Community Development Innovation Council and leader of a task force focused on improvements along Third St. SE.

During Prince’s time as executive director, TCR endured and returned from the flood of 2008, completed an $8 million renovation of the Iowa Theater building, seeded a $2 million endowment, and increased annual attendance.

Prince will continue at TCR through the end of October, according to the release.

Stay with thegazette.com for updates on this story.

Give us feedback

We value your trust and work hard to provide fair, accurate coverage. If you have found an error or omission in our reporting, tell us here.

Or if you have a story idea we should look into? Tell us here.

CONTINUE READING

MORE Business ARTICLES TO READ NEXT ...

Many U.S. businesses may be surprised to learn that the European Union's new data privacy rules could impact them, too. The EU's General Data Protection Regulation (GDPR) will take effect May 25 and imposes strict new rules about ...

Chinese investors are pumping money into U.S. drug start-ups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health businesses.Venture-capital funds based in China p ...

Give us feedback

We value your trust and work hard to provide fair, accurate coverage. If you have found an error or omission in our reporting, tell us here.

Or if you have a story idea we should look into? Tell us here.